… Malignant neuroendocrine tumours (NETs) constitute a rare and heterogeneous group of
tumours including the neuroendocrine adrenal, as well as endocrine islets within glandular …

… Neuroendocrine tumours (NETs) have unique properties that are important to consider for
radiological and nuclear medicine imaging. NETs arise from the cells of the diffuse endocrine …

… very high urinary radioactivity … imaging work-up in patients with neuroendocrine tumours
varies considerably depending on the type of primary tumour and the individual patient's tumour …

… , has a diagnostic sensitivity superior to that of conventional radiological imaging.
Radiolabelled monoclonal antibodies have at present only a storical value, while a series of new …

… Low amounts of administered radioactivity and short scanning times can partly explain the
low sensitivity of some of the studies included in this review. For optimal results with 111 In-…

… Guideline for PET/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated …
of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging. …

… At present SRI should be limited to those cases in which imaging with other nuclear
medicine or radiological procedures produces inconclusive results, and to the assessment of …

… advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
… 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J …

… procedures such as 18FFDG-PET and SRS, conventional imaging techniques … an
neuroendocrine disease. One significant advantage of radionuclide imaging over radiological …

… Radiolabeled MIBG imaging is characterized by high specificity with very few (1-5%) false-positive
findings, ie, as a result of retention of radioactivity in the urinary tract, or the presence …